Crossmark

Development of Novel Patient-Reported Outcome (PRO) and Observer-Reported Outcome (ObsRO) Instruments in Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA): ViSIO-PRO and ViSIO-ObsRO

Crossref DOI link: https://doi.org/10.1007/s40123-023-00724-x

Published Online: 2023-05-21

Published Print: 2023-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Audo, Isabelle

Patalano, Francesco https://orcid.org/0000-0001-7015-6084
Naujoks, Christel https://orcid.org/0000-0002-3799-6521
Spera, Claudio

Fischer, M. Dominik

Green, Jane

Kay, Christine

Durham, Todd https://orcid.org/0000-0002-0363-0329
Williamson, Nicola

Bradley, Helena https://orcid.org/0000-0002-7077-2183
Barclay, Melissa

Boparai, Kieran

Banhazi, Judit
Funding

Funding for this research was provided by:

Novartis Pharma
License Information

Text and Data Mining valid from 2023-05-21

Version of Record valid from 2023-05-21
More Information

Article History

Received: 23 March 2023

Accepted: 20 April 2023

First Online: 21 May 2023

Document is current

Any future updates will be listed below